Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1959 1
1961 7
1962 2
1963 3
1964 6
1965 4
1966 4
1968 1
1969 10
1970 7
1971 2
1972 3
1973 5
1974 14
1975 10
1976 4
1977 5
1978 13
1979 14
1980 16
1981 18
1982 22
1983 26
1984 21
1985 25
1986 21
1987 31
1988 25
1989 43
1990 48
1991 54
1992 43
1993 63
1994 79
1995 85
1996 87
1997 81
1998 78
1999 75
2000 85
2001 65
2002 66
2003 74
2004 77
2005 77
2006 66
2007 82
2008 79
2009 67
2010 85
2011 67
2012 76
2013 72
2014 77
2015 98
2016 133
2017 160
2018 128
2019 100
2020 99
2021 104
2022 102
2023 102
2024 49

Text availability

Article attribute

Article type

Publication date

Search Results

2,990 results

Results by year

Filters applied: . Clear all
Page 1
Colon cancer with perforation.
Otani K, Kawai K, Hata K, Tanaka T, Nishikawa T, Sasaki K, Kaneko M, Murono K, Emoto S, Nozawa H. Otani K, et al. Among authors: nishikawa t. Surg Today. 2019 Jan;49(1):15-20. doi: 10.1007/s00595-018-1661-8. Epub 2018 Apr 24. Surg Today. 2019. PMID: 29691659 Review.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: nishikawa t. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.
Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J. Mulatero P, et al. Among authors: nishikawa t. J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510. J Hypertens. 2020. PMID: 32890264 Free article.
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Yamashita Y, et al. Among authors: nishikawa t. Circulation. 2023 Nov 21;148(21):1665-1676. doi: 10.1161/CIRCULATIONAHA.123.066360. Epub 2023 Aug 28. Circulation. 2023. PMID: 37638968 Clinical Trial.
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial.
Nishikawa T, Hasegawa K, Matsumoto K, Mori M, Hirashima Y, Takehara K, Ariyoshi K, Kato T, Yagishita S, Hamada A, Kawasaki M, Kawashima S, Tomatsuri S, Nagasaka Y, Yoshida H, Machida R, Hirakawa A, Nakamura K, Yonemori K. Nishikawa T, et al. J Clin Oncol. 2023 May 20;41(15):2789-2799. doi: 10.1200/JCO.22.02558. Epub 2023 Mar 28. J Clin Oncol. 2023. PMID: 36977309 Free PMC article.
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.
Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators. Williams TA, et al. Among authors: nishikawa t. Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30. Lancet Diabetes Endocrinol. 2017. PMID: 28576687 Free PMC article.
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study.
Williams TA, Gong S, Tsurutani Y, Tezuka Y, Thuzar M, Burrello J, Wu VC, Yamazaki Y, Mulatero P, Sasano H, Stowasser M, Nishikawa T, Satoh F, Reincke M. Williams TA, et al. Among authors: nishikawa t. Lancet Diabetes Endocrinol. 2022 Nov;10(11):769-771. doi: 10.1016/S2213-8587(22)00253-4. Epub 2022 Sep 19. Lancet Diabetes Endocrinol. 2022. PMID: 36137555 No abstract available.
Mixed corticomedullary tumor of the adrenal gland.
Kimura N, Motoyama T, Saito J, Nishikawa T. Kimura N, et al. Among authors: nishikawa t. Front Endocrinol (Lausanne). 2022 Sep 16;13:1026918. doi: 10.3389/fendo.2022.1026918. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36187098 Free PMC article. Review.
Tetrodotoxins in the flatworm Planocera multitentaculata.
Suo R, Tanaka M, Oyama H, Kojima Y, Yui K, Sakakibara R, Nakahigashi R, Adachi M, Nishikawa T, Sugita H, Itoi S. Suo R, et al. Among authors: nishikawa t. Toxicon. 2022 Sep;216:169-173. doi: 10.1016/j.toxicon.2022.07.001. Epub 2022 Jul 16. Toxicon. 2022. PMID: 35843466
2,990 results